http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107303384-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-331
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-062
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-538
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-238
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-9066
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-9068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-902
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-899
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-8994
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-484
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-488
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-284
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-258
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-884
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-725
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-746
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-9068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
filingDate 2017-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-107303384-B
titleOfInvention A traditional Chinese medicine composition with curative effect on various symptoms and its derivatives and products
abstract The invention provides a traditional Chinese medicine composition with curative effect on various symptoms and derivatives and products thereof, belonging to the field of traditional Chinese medicine, and is characterized in that, 1-3 parts by weight of crude drug A, 0.6-1.5 parts by weight of crude drug B, 0.6-1.5 parts by weight of crude drug C and 0-1.5 parts by weight of crude drug D are composed; Described crude drug A is licorice root, raw licorice, jujube and/or barley; Described crude drug B is red ginseng Described crude drug C is fried Atractylodes; Described crude drug D is 1 weight part of dried ginger or turmeric or Poria, and this multi-indication Chinese medicine composition can be coordinated with multiple crude drugs to derive the Chinese medicine combination that adapts to different symptoms thing.
priorityDate 2016-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11968069
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426185971
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527139
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14982

Total number of triples: 66.